Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Who Are Not Achieving Glycemic Targets
Public ClinicalTrials.gov record NCT07502495. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Randomized, Double-blind, Placebo-Controlled Trial Assessing the Efficacy and Safety of Icovamenib in Participants With Type 2 Diabetes Who Are Not Achieving Glycemic Targets Despite Antihyperglycemic Medications
Study identification
- NCT ID
- NCT07502495
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Biomea Fusion Inc.
- Industry
- Enrollment
- 60 participants
Conditions and interventions
Conditions
Interventions
- Placebo Drug
- icovamenib 100mg Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 26, 2026
- Primary completion
- May 31, 2027
- Completion
- Jun 30, 2027
- Last update posted
- May 11, 2026
2026 – 2027
United States locations
- U.S. sites
- 16
- U.S. states
- 8
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Central Research Associates, LLC dba Flourish Research | Birmingham | Alabama | 35205 | Recruiting |
| Hope Clinical Research | Canoga Park | California | 91303 | Recruiting |
| Ark Clinical Research | Long Beach | California | 90815 | Recruiting |
| Catalina Research Institute, LLC | Montclair | California | 91763 | Recruiting |
| Paradigm Clinical Research Centers, LLC | San Diego | California | 92108 | Recruiting |
| Southwest General Healthcare Center | Fort Myers | Florida | 33907 | Recruiting |
| Panax Clinical Research | Miami Lakes | Florida | 33014 | Recruiting |
| Clinical Site Partners, LLC dba Flourish Research | Winter Park | Florida | 32789 | Recruiting |
| David Kavtaradze MD, Inc | Cordele | Georgia | 31015 | Recruiting |
| Excel Clinical Research | Las Vegas | Nevada | 89109 | Recruiting |
| Diabetes and Endocrinology Associates of Stark County | Canton | Ohio | 44718 | Recruiting |
| Elligo Health Research, Inc. | Austin | Texas | 78704 | Recruiting |
| Zenos Clinical Research | Dallas | Texas | 75230 | Recruiting |
| Synergy Groups Medical | Houston | Texas | 77061 | Recruiting |
| Epic Clinical Research | Lewisville | Texas | 75057 | Recruiting |
| Manassas Clinical Research Center | Manassas | Virginia | 20110 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07502495, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 11, 2026 · Synced May 13, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07502495 live on ClinicalTrials.gov.